Secora Michael has filed 126 insider transactions across 1 company since February 2022.
Most recent transaction: a tax payment of 11937 shares of RECURSION PHARMACEUTICALS, INC. ($RXRX) on November 15, 2024.
Activity breakdown: 0 open-market purchases and 39 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 11937 | $6.18 | 1,487,694.0000 | 0 | 0.80% | 0.00% |
| Nov. 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,490,256.0000 | 0 | 2.71% | 0.00% |
| Nov. 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $7.64 | 1,475,256.0000 | 0 | 1.01% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,514,631.0000 | 0 | 2.67% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $7.66 | 1,499,631.0000 | 0 | 0.99% | 0.00% |
| Nov. 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 1,936,022.0000 | 0 | 1.99% | 0.00% |
| Nov. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 1,896,647.0000 | 0 | 2.03% | 0.00% |
| Oct. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,441,506.0000 | 0 | 2.81% | 0.00% |
| Oct. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.32 | 1,426,506.0000 | 0 | 1.04% | 0.00% |
| Oct. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,465,881.0000 | 0 | 2.76% | 0.00% |
| Oct. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.36 | 1,450,881.0000 | 0 | 1.02% | 0.00% |
| Oct. 8, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,014,772.0000 | 0 | 1.92% | 0.00% |
| Oct. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 1,975,397.0000 | 0 | 1.95% | 0.00% |
| Sept. 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,392,756.0000 | 0 | 2.91% | 0.00% |
| Sept. 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.17 | 1,377,756.0000 | 0 | 1.08% | 0.00% |
| Sept. 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,417,131.0000 | 0 | 2.86% | 0.00% |
| Sept. 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.32 | 1,402,131.0000 | 0 | 1.06% | 0.00% |
| Sept. 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,093,522.0000 | 0 | 1.85% | 0.00% |
| Sept. 11, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,054,147.0000 | 0 | 1.88% | 0.00% |
| Aug. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 11962 | $6.69 | 1,353,381.0000 | 0 | 0.88% | 0.00% |
| Aug. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,355,968.0000 | 0 | 2.99% | 0.00% |
| Aug. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.35 | 1,340,968.0000 | 0 | 1.11% | 0.00% |
| Aug. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,380,343.0000 | 0 | 2.94% | 0.00% |
| Aug. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $6.35 | 1,365,343.0000 | 0 | 1.09% | 0.00% |
| Aug. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,172,272.0000 | 0 | 1.78% | 0.00% |
| Aug. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,132,897.0000 | 0 | 1.81% | 0.00% |
| July 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,307,218.0000 | 0 | 3.11% | 0.00% |
| July 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $7.32 | 1,292,218.0000 | 0 | 1.15% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,331,593.0000 | 0 | 3.05% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $7.24 | 1,316,593.0000 | 0 | 1.13% | 0.00% |
| July 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,251,022.0000 | 0 | 1.72% | 0.00% |
| July 10, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,211,647.0000 | 0 | 1.75% | 0.00% |
| June 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,258,468.0000 | 0 | 3.23% | 0.00% |
| June 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $9.32 | 1,243,468.0000 | 0 | 1.19% | 0.00% |
| June 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 39375 | $2.22 | 1,282,843.0000 | 0 | 3.17% | 0.00% |
| June 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 15000 | $9.27 | 1,267,843.0000 | 0 | 1.17% | 0.00% |
| June 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,329,772.0000 | 0 | 1.66% | 0.00% |
| June 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 39375 | $0.00 | 2,290,397.0000 | 0 | 1.69% | 0.00% |
| May 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 11962 | $10.01 | 1,219,093.0000 | 0 | 0.97% | 0.00% |
| April 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,241,679.0000 | 0 | 3.11% | 0.00% |
| April 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $7.67 | 1,216,679.0000 | 0 | 2.01% | 0.00% |
| April 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,254,179.0000 | 0 | 3.08% | 0.00% |
| April 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 23124 | $7.58 | 1,231,055.0000 | 0 | 1.84% | 0.00% |
| April 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,406,647.0000 | 0 | 1.53% | 0.00% |
| April 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,369,147.0000 | 0 | 1.56% | 0.00% |
| March 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,216,679.0000 | 0 | 3.18% | 0.00% |
| March 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $10.46 | 1,191,679.0000 | 0 | 2.05% | 0.00% |
| March 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,229,179.0000 | 0 | 3.15% | 0.00% |
| March 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $11.03 | 1,204,179.0000 | 0 | 2.03% | 0.00% |
| March 12, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,481,647.0000 | 0 | 1.49% | 0.00% |
| March 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,444,147.0000 | 0 | 1.51% | 0.00% |
| Feb. 15, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 7172 | $12.43 | 1,179,179.0000 | 0 | 0.60% | 0.00% |
| Feb. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,198,851.0000 | 0 | 3.23% | 0.00% |
| Feb. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $9.86 | 1,173,851.0000 | 0 | 2.09% | 0.00% |
| Feb. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,211,351.0000 | 0 | 3.19% | 0.00% |
| Feb. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 23933 | $10.43 | 1,187,418.0000 | 0 | 1.98% | 0.00% |
| Feb. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 1067 | $10.98 | 1,186,351.0000 | 0 | 0.09% | 0.00% |
| Feb. 13, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,556,647.0000 | 0 | 1.45% | 0.00% |
| Feb. 14, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,519,147.0000 | 0 | 1.47% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 8659 | $0.00 | 989,673.0000 | 0 | 0.88% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 174190 | $0.00 | 1,163,863.0000 | 0 | 17.60% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 2512 | $10.09 | 1,161,351.0000 | 0 | 0.22% | 0.00% |
| Feb. 9, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 348380 | $0.00 | 2,594,147.0000 | 0 | 15.51% | 0.00% |
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 993,514.0000 | 0 | 3.92% | 0.00% |
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $10.45 | 968,514.0000 | 0 | 2.52% | 0.00% |
| Jan. 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 1,006,014.0000 | 0 | 3.87% | 0.00% |
| Jan. 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $10.25 | 981,014.0000 | 0 | 2.49% | 0.00% |
| Jan. 16, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,283,267.0000 | 0 | 1.62% | 0.00% |
| Jan. 17, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,245,767.0000 | 0 | 1.64% | 0.00% |
| Dec. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $7.39 | 943,514.0000 | 0 | 2.58% | 0.00% |
| Dec. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 981,014.0000 | 0 | 3.97% | 0.00% |
| Dec. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 968,514.0000 | 0 | 4.03% | 0.00% |
| Dec. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $7.59 | 956,014.0000 | 0 | 2.55% | 0.00% |
| Dec. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,358,267.0000 | 0 | 1.57% | 0.00% |
| Dec. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,320,767.0000 | 0 | 1.59% | 0.00% |
| Nov. 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 950,686.0000 | 0 | 4.11% | 0.00% |
| Nov. 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $6.32 | 925,686.0000 | 0 | 2.63% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 963,186.0000 | 0 | 4.05% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 20300 | $7.25 | 942,886.0000 | 0 | 2.11% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 4700 | $7.62 | 938,186.0000 | 0 | 0.50% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 7172 | $7.18 | 931,014.0000 | 0 | 0.76% | 0.00% |
| Nov. 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,433,267.0000 | 0 | 1.52% | 0.00% |
| Nov. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,395,767.0000 | 0 | 1.54% | 0.00% |
| Oct. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 925,686.0000 | 0 | 4.22% | 0.00% |
| Oct. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $7.07 | 900,686.0000 | 0 | 2.70% | 0.00% |
| Oct. 11, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 938,186.0000 | 0 | 4.16% | 0.00% |
| Oct. 11, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $6.85 | 913,186.0000 | 0 | 2.66% | 0.00% |
| Oct. 10, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,508,267.0000 | 0 | 1.47% | 0.00% |
| Oct. 11, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,470,767.0000 | 0 | 1.50% | 0.00% |
| Sept. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 900,686.0000 | 0 | 4.34% | 0.00% |
| Sept. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $8.43 | 875,686.0000 | 0 | 2.78% | 0.00% |
| Sept. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 913,186.0000 | 0 | 4.28% | 0.00% |
| Sept. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $8.69 | 888,186.0000 | 0 | 2.74% | 0.00% |
| Sept. 12, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,583,267.0000 | 0 | 1.43% | 0.00% |
| Sept. 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,545,767.0000 | 0 | 1.45% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $9.27 | 850,686.0000 | 0 | 2.85% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 4727 | $9.19 | 838,186.0000 | 0 | 0.56% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 875,686.0000 | 0 | 4.47% | 0.00% |
| Aug. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 888,186.0000 | 0 | 4.41% | 0.00% |
| Aug. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $8.90 | 863,186.0000 | 0 | 2.81% | 0.00% |
| Aug. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,695,767.0000 | 0 | 1.37% | 0.00% |
| Aug. 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,620,767.0000 | 0 | 1.41% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 24500 | $13.62 | 830,913.0000 | 0 | 2.86% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 500 | $14.05 | 830,413.0000 | 0 | 0.06% | 0.00% |
| July 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 867,913.0000 | 0 | 4.52% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 855,413.0000 | 0 | 4.58% | 0.00% |
| July 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 1991 | $14.36 | 865,922.0000 | 0 | 0.23% | 0.00% |
| July 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 13150 | $15.36 | 852,772.0000 | 0 | 1.52% | 0.00% |
| July 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 9859 | $16.00 | 842,913.0000 | 0 | 1.16% | 0.00% |
| July 18, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,733,268.0000 | 0 | 1.35% | 0.00% |
| July 19, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,695,768.0000 | 0 | 1.37% | 0.00% |
| June 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $10.07 | 817,913.0000 | 0 | 2.97% | 0.00% |
| June 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 830,413.0000 | 0 | 4.73% | 0.00% |
| June 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | S | Class A Common Stock | 25000 | $9.93 | 805,413.0000 | 0 | 3.01% | 0.00% |
| June 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Class A Common Stock | 37500 | $2.22 | 842,913.0000 | 0 | 4.66% | 0.00% |
| June 13, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,808,268.0000 | 0 | 1.32% | 0.00% |
| June 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 37500 | $0.00 | 2,770,768.0000 | 0 | 1.34% | 0.00% |
| May 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 4760 | $5.60 | 790,159.0000 | 0 | 0.60% | 0.00% |
| Feb. 4, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 678 | $11.40 | 590,380.0000 | 0 | 0.11% | 0.00% |
| Feb. 4, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 58342 | $0.00 | 589,101.0000 | 0 | 10.99% | 0.00% |
| Feb. 4, 2022 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 1957 | $0.00 | 591,058.0000 | 0 | 0.33% | 0.00% |
| Feb. 15, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 1258 | $8.44 | 794,310.0000 | 0 | 0.16% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | F | Class A Common Stock | 2669 | $8.55 | 795,568.0000 | 0 | 0.33% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 404857 | $0.00 | 404,857.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 202428 | $0.00 | 790,502.0000 | 0 | 34.42% | 0.00% |
| Feb. 1, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Secora Michael | Chief Financial Officer | A | Class A Common Stock | 7735 | $0.00 | 798,237.0000 | 0 | 0.98% | 0.00% |